SCHEMBL9105927

SCHEMBL9105927

CC(C)CC(C(=O)Nc1ccccn1)N1C(=O)C(=O)c2c(Cl)cccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 3/20 0.45
RAB9A P51151 3/20 0.43
LMNA P02545 1/20 0.43
RIPK1 Q13546 1/20 0.43
FFAR2 O15552 1/20 0.43
NPC1 O15118 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 4/20 0.42
REN P00797 1/20 0.41
KDM4E B2RXH2 1/20 0.41
S1PR1 P21453 1/20 0.41
S1PR3 Q99500 1/20 0.41
MMP1 P03956 2/20 0.41
MMP3 P08254 2/20 0.41
MMP9 P14780 2/20 0.41
CDK4 P11802 1/20 0.40
CCND2 P30279 1/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9908079 0.88 KDM4E (0.44) GCKRAB9AFFAR2NPC1MEN1
SCHEMBL9106900 0.88 KDM4E (0.44) GCKRAB9AFFAR2NPC1MEN1
SCHEMBL9108958 0.85 GCK (0.53) GCKRAB9ALMNANPC1MEN1
SCHEMBL9106999 0.84 GCK (0.56) GCKALDH1A1KDM4ES1PR1S1PR3
SCHEMBL9908080 0.83 GCK (0.41) GCKRAB9ALMNANPC1ALDH1A1
SCHEMBL9104263 0.83 FFAR2 (0.47) GCKRAB9ALMNARIPK1FFAR2
SCHEMBL9103795 0.82 FFAR2 (0.46) GCKRAB9ALMNARIPK1FFAR2
SCHEMBL9101953 0.82 GCK (0.66) GCKRAB9ALMNAFFAR2NPC1
SCHEMBL9107359 0.82 RAB9A (0.44) GCKRAB9ALMNARIPK1FFAR2
SCHEMBL1316390 0.80 GCK (0.67) GCKRAB9ALMNANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT GCK 488/4885RAB9A 1778/4885LMNA 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.